State Board of Administration of Florida Retirement System Sells 260 Shares of Atrion Co. (NASDAQ:ATRI)

State Board of Administration of Florida Retirement System decreased its stake in shares of Atrion Co. (NASDAQ:ATRIGet Rating) by 32.5% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 540 shares of the medical instruments supplier’s stock after selling 260 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Atrion were worth $340,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of ATRI. NewEdge Wealth LLC bought a new stake in shares of Atrion during the 1st quarter worth about $664,000. Boston Trust Walden Corp boosted its holdings in shares of Atrion by 1.1% during the 2nd quarter. Boston Trust Walden Corp now owns 43,683 shares of the medical instruments supplier’s stock worth $27,470,000 after buying an additional 474 shares during the period. Bridgewater Associates LP boosted its holdings in shares of Atrion by 28.5% during the 1st quarter. Bridgewater Associates LP now owns 1,985 shares of the medical instruments supplier’s stock worth $1,415,000 after buying an additional 440 shares during the period. ProShare Advisors LLC boosted its holdings in Atrion by 3.0% in the 1st quarter. ProShare Advisors LLC now owns 14,341 shares of the medical instruments supplier’s stock valued at $10,225,000 after purchasing an additional 424 shares during the period. Finally, Goldman Sachs Group Inc. boosted its holdings in Atrion by 22.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,913 shares of the medical instruments supplier’s stock valued at $1,364,000 after purchasing an additional 345 shares during the period. Institutional investors own 65.68% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com downgraded shares of Atrion from a “buy” rating to a “hold” rating in a report on Tuesday, November 8th.

Atrion Stock Up 0.1 %

NASDAQ ATRI opened at $606.00 on Monday. The company has a market capitalization of $1.07 billion, a P/E ratio of 31.32 and a beta of 0.28. Atrion Co. has a 12-month low of $542.10 and a 12-month high of $788.00. The firm has a 50-day moving average price of $603.39 and a two-hundred day moving average price of $620.69.

Atrion Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 15th. Stockholders of record on Thursday, December 1st will be given a $2.15 dividend. This represents a $8.60 annualized dividend and a dividend yield of 1.42%. The ex-dividend date of this dividend is Wednesday, November 30th. Atrion’s payout ratio is presently 44.44%.

Insider Activity

In other news, CFO Jeffery Strickland sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 26th. The shares were sold at an average price of $675.00, for a total value of $675,000.00. Following the completion of the transaction, the chief financial officer now directly owns 1,532 shares in the company, valued at approximately $1,034,100. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 22.65% of the company’s stock.

About Atrion

(Get Rating)

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.

Read More

Want to see what other hedge funds are holding ATRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Atrion Co. (NASDAQ:ATRIGet Rating).

Institutional Ownership by Quarter for Atrion (NASDAQ:ATRI)

Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.